RELIFRONT Trademark

Trademark Overview

On Tuesday, July 22, 2014, a trademark application was filed for RELIFRONT with the United States Patent and Trademark Office. The USPTO has given the RELIFRONT trademark a serial number of 86344053. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 5, 2018. This trademark is owned by Merck Sharp & Dohme Corp.. The RELIFRONT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders
relifront

General Information

Serial Number86344053
Word MarkRELIFRONT
Filing DateTuesday, July 22, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 5, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 2, 2014

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of autoimmune diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 30, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMerck Sharp & Dohme Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889
Party NameMerck Sharp & Dohme Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWhitehouse Station, NJ 08889

Trademark Events

Event DateEvent Description
Monday, March 5, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 5, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, July 4, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 3, 2017EXTENSION 5 GRANTED
Wednesday, June 21, 2017EXTENSION 5 FILED
Wednesday, June 21, 2017TEAS EXTENSION RECEIVED
Friday, January 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 4, 2017EXTENSION 4 GRANTED
Wednesday, January 4, 2017EXTENSION 4 FILED
Wednesday, January 4, 2017TEAS EXTENSION RECEIVED
Tuesday, June 28, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 27, 2016EXTENSION 3 GRANTED
Thursday, June 16, 2016EXTENSION 3 FILED
Thursday, June 16, 2016TEAS EXTENSION RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 30, 2016EXTENSION 2 GRANTED
Monday, December 14, 2015EXTENSION 2 FILED
Thursday, January 28, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 14, 2015TEAS EXTENSION RECEIVED
Saturday, July 4, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 2, 2015EXTENSION 1 GRANTED
Thursday, July 2, 2015EXTENSION 1 FILED
Thursday, July 2, 2015TEAS EXTENSION RECEIVED
Tuesday, January 27, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 2, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 2, 2014PUBLISHED FOR OPPOSITION
Wednesday, November 12, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 27, 2014LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 24, 2014ASSIGNED TO EXAMINER
Tuesday, September 2, 2014PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Monday, August 25, 2014ASSIGNED TO LIE
Monday, August 18, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, July 30, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, July 25, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

relifront diseases disorders autoimmune treatment preparations pharmaceutical